PMC:7195088 / 34651-35170 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1035","span":{"begin":191,"end":195},"obj":"Gene"},{"id":"1036","span":{"begin":197,"end":210},"obj":"Gene"},{"id":"1037","span":{"begin":427,"end":437},"obj":"Species"},{"id":"1038","span":{"begin":439,"end":486},"obj":"Species"},{"id":"1039","span":{"begin":0,"end":4},"obj":"Disease"},{"id":"1040","span":{"begin":7,"end":42},"obj":"Disease"},{"id":"1041","span":{"begin":79,"end":103},"obj":"Disease"}],"attributes":[{"id":"A1035","pred":"tao:has_database_id","subj":"1035","obj":"Gene:3552"},{"id":"A1036","pred":"tao:has_database_id","subj":"1036","obj":"Gene:3552"},{"id":"A1037","pred":"tao:has_database_id","subj":"1037","obj":"Tax:2697049"},{"id":"A1038","pred":"tao:has_database_id","subj":"1038","obj":"Tax:2697049"},{"id":"A1039","pred":"tao:has_database_id","subj":"1039","obj":"MESH:D012128"},{"id":"A1040","pred":"tao:has_database_id","subj":"1040","obj":"MESH:D012128"},{"id":"A1041","pred":"tao:has_database_id","subj":"1041","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ARDS = acute respiratory distress syndrome; CI, confidence interval; COVID-19, coronavirus disease 2019; CT, computed tomography; EOT, end of treatment; HR, hazard ratio; Ig, immunoglobulin; IL-1, interleukin 1; IQR, interquartile range; ITT, intent to treat; mITT, modified intent to treat; Pao2/Fio2, of arterial oxygen partial pressure to fractional inspired oxygen; RCT, randomized controlled trial; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T52","span":{"begin":175,"end":189},"obj":"Body_part"},{"id":"T53","span":{"begin":191,"end":195},"obj":"Body_part"},{"id":"T54","span":{"begin":191,"end":193},"obj":"Body_part"},{"id":"T55","span":{"begin":197,"end":210},"obj":"Body_part"},{"id":"T56","span":{"begin":197,"end":208},"obj":"Body_part"}],"attributes":[{"id":"A52","pred":"fma_id","subj":"T52","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A53","pred":"fma_id","subj":"T53","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A55","pred":"fma_id","subj":"T55","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A56","pred":"fma_id","subj":"T56","obj":"http://purl.org/sig/ont/fma/fma86578"}],"text":"ARDS = acute respiratory distress syndrome; CI, confidence interval; COVID-19, coronavirus disease 2019; CT, computed tomography; EOT, end of treatment; HR, hazard ratio; Ig, immunoglobulin; IL-1, interleukin 1; IQR, interquartile range; ITT, intent to treat; mITT, modified intent to treat; Pao2/Fio2, of arterial oxygen partial pressure to fractional inspired oxygen; RCT, randomized controlled trial; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T34","span":{"begin":13,"end":33},"obj":"Phenotype"}],"attributes":[{"id":"A34","pred":"hp_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"ARDS = acute respiratory distress syndrome; CI, confidence interval; COVID-19, coronavirus disease 2019; CT, computed tomography; EOT, end of treatment; HR, hazard ratio; Ig, immunoglobulin; IL-1, interleukin 1; IQR, interquartile range; ITT, intent to treat; mITT, modified intent to treat; Pao2/Fio2, of arterial oxygen partial pressure to fractional inspired oxygen; RCT, randomized controlled trial; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T178","span":{"begin":0,"end":4},"obj":"Disease"},{"id":"T179","span":{"begin":7,"end":42},"obj":"Disease"},{"id":"T180","span":{"begin":13,"end":42},"obj":"Disease"},{"id":"T181","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"T182","span":{"begin":79,"end":103},"obj":"Disease"},{"id":"T183","span":{"begin":427,"end":435},"obj":"Disease"},{"id":"T184","span":{"begin":439,"end":486},"obj":"Disease"},{"id":"T185","span":{"begin":439,"end":472},"obj":"Disease"}],"attributes":[{"id":"A178","pred":"mondo_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A179","pred":"mondo_id","subj":"T179","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A180","pred":"mondo_id","subj":"T180","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A181","pred":"mondo_id","subj":"T181","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A182","pred":"mondo_id","subj":"T182","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A183","pred":"mondo_id","subj":"T183","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A184","pred":"mondo_id","subj":"T184","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A185","pred":"mondo_id","subj":"T185","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ARDS = acute respiratory distress syndrome; CI, confidence interval; COVID-19, coronavirus disease 2019; CT, computed tomography; EOT, end of treatment; HR, hazard ratio; Ig, immunoglobulin; IL-1, interleukin 1; IQR, interquartile range; ITT, intent to treat; mITT, modified intent to treat; Pao2/Fio2, of arterial oxygen partial pressure to fractional inspired oxygen; RCT, randomized controlled trial; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T192","span":{"begin":197,"end":210},"obj":"http://purl.obolibrary.org/obo/PR_000001091"},{"id":"T193","span":{"begin":306,"end":314},"obj":"http://purl.obolibrary.org/obo/UBERON_0001637"},{"id":"T194","span":{"begin":306,"end":314},"obj":"http://www.ebi.ac.uk/efo/EFO_0000814"},{"id":"T195","span":{"begin":506,"end":518},"obj":"http://purl.obolibrary.org/obo/OBI_0000245"}],"text":"ARDS = acute respiratory distress syndrome; CI, confidence interval; COVID-19, coronavirus disease 2019; CT, computed tomography; EOT, end of treatment; HR, hazard ratio; Ig, immunoglobulin; IL-1, interleukin 1; IQR, interquartile range; ITT, intent to treat; mITT, modified intent to treat; Pao2/Fio2, of arterial oxygen partial pressure to fractional inspired oxygen; RCT, randomized controlled trial; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T474","span":{"begin":191,"end":193},"obj":"Chemical"},{"id":"T476","span":{"begin":315,"end":321},"obj":"Chemical"},{"id":"T477","span":{"begin":362,"end":368},"obj":"Chemical"}],"attributes":[{"id":"A474","pred":"chebi_id","subj":"T474","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A475","pred":"chebi_id","subj":"T474","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A476","pred":"chebi_id","subj":"T476","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"},{"id":"A477","pred":"chebi_id","subj":"T477","obj":"http://purl.obolibrary.org/obo/CHEBI_25805"}],"text":"ARDS = acute respiratory distress syndrome; CI, confidence interval; COVID-19, coronavirus disease 2019; CT, computed tomography; EOT, end of treatment; HR, hazard ratio; Ig, immunoglobulin; IL-1, interleukin 1; IQR, interquartile range; ITT, intent to treat; mITT, modified intent to treat; Pao2/Fio2, of arterial oxygen partial pressure to fractional inspired oxygen; RCT, randomized controlled trial; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."}

{"project":"LitCovid-sentences","denotations":[{"id":"T279","span":{"begin":0,"end":519},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ARDS = acute respiratory distress syndrome; CI, confidence interval; COVID-19, coronavirus disease 2019; CT, computed tomography; EOT, end of treatment; HR, hazard ratio; Ig, immunoglobulin; IL-1, interleukin 1; IQR, interquartile range; ITT, intent to treat; mITT, modified intent to treat; Pao2/Fio2, of arterial oxygen partial pressure to fractional inspired oxygen; RCT, randomized controlled trial; RT-PCR, real-time PCR; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."}